Atypical neoplastic solitary focal uptake of 18F-PSMA-1007 in PET/CT in patients with biochemically recurrent prostate cancer
Authors:
- T. L. AntonevskayaTAT. L. Antonevskaya
- A. I. KhalimonAKA. I. Khalimon
- M. M. KhodzhibekovaMKM. M. Khodzhibekova
- L. U. AtakishievaLAL. U. Atakishieva
- G. F. KhamadeevaGKG. F. Khamadeeva
- D. Yu. KhodakovaDKD. Yu. Khodakova
- T. N. LazutinaTLT. N. Lazutina
- I. V. PylovaIPI. V. Pylova
- N. N. VolchenkoNVN. N. Volchenko
- A. V. LeontyevALA. V. Leontyev
Open Access
- 29 December 2023
- journal article
- research article
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 19 (4) , 131-138-138
Abstract
It is established that prostate-specific membrane antigen (PSMA), despite its name, is expressed in many tissues other than the prostate gland, both within physiological conditions and in various pathological processes. Additionally, apart from prostate cancer, other malignant tumors are characterized by increased PSMA expression which, according to many authors, is associated with neoangiogenesis. These factors are reflected in the results of PSMA-radioligand imaging and require comprehensive approach to image interpretation including evaluation of computed tomography and magnetic resonance semiotics. In addition, rare cases of distant visceral prostate cancer metastasis in the form of solitary lesions also should be considered during interpretation of the results of radiologic imaging including positron emission tomography/computed tomography.We present two clinical cases in which positron emission tomography/computed tomography revealed solitary foci of pathological [18F]PSMA-1007 uptake outside the areas of typical metastatic spread (with exception of advanced disease)of prostate cancer, specifically in the stomach wall and the left cerebellar hemisphere. In the first case histologicalexamination results revealed a metachronous low grade neuroendocrine tumor of the stomach, in the second case a metastatic lesion of the cerebellum was diagnosed as part of the underlying disease.Keywords
This publication has 15 references indexed in Scilit:
- Prostate-specific Membrane Antigen Reporting and Data System Version 2.0European Urology, 2023
- PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2023
- Практические рекомендации по лечению рака предстательной железыMalignant tumours, 2021
- Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- 68 Ga-PSMA PET/CT in prostate cancerRevista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2018
- Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen–Targeted PET Imaging: PSMA-RADS Version 1.0Journal of Nuclear Medicine, 2017
- Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine TumorClinical Nuclear Medicine, 2016
- Solitary brain metastasis from prostate cancer: a case reportAnnals of Palliative Medicine, 2016
- Brain metastasis from prostate carcinomaCancer, 2003
- Brain metastasis from prostate carcinomaCancer, 1999